US Stock MarketDetailed Quotes
BTTX Better Therapeutics
- 0.009
- +0.001+15.68%
15min DelayClose Apr 25 16:00 ET
490.64KMarket Cap-8P/E (TTM)
0.015High0.008Low547.88KVolume0.008Open0.008Pre Close7.23KTurnover2.26%Turnover RatioLossP/E (Static)54.52MShares1.35052wk High-0.05P/B218.15KFloat Cap0.00552wk Low--Dividend TTM24.24MShs Float29.400Historical High--Div YieldTTM89.97%Amplitude0.005Historical Low0.013Avg Price1Lot Size
About Better Therapeutics Company
Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.
Company Profile
SymbolBTTX
Company NameBetter Therapeutics
Listing DateMar 17, 2021
Founded2015
CEOMr. Craig R. Jalbert
MarketPink Market
Employees54
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address548 Market Street,Suite 49404
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94104
Phone1-415-887-2311
Websitehttp://www.bettertx.com
Company Executives
- Name
- Position
- Salary
- Craig R. Jalbert
- Director, President, Chief Executive Officer, Treasurer, Secretary, Principal Financial Officer and Principal Accounting Officer
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
